Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Editor's Note: Listeria monocytogenes Promotes Tumor Growth via Tumor Cell Toll-Like Receptor 2 Signaling.

Huang B, Zhao J, Shen S, Li H, He KL, Shen GX, Mayer L, Unkeless J, Li D, Yuan Y, Zhang GM, Xiong H, Feng ZH.

Cancer Res. 2019 Aug 15;79(16):4306. doi: 10.1158/0008-5472.CAN-19-1891. No abstract available.

PMID:
31416850
2.

Editor's Note: Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune Surveillance.

Huang B, Zhao J, Li H, He KL, Chen Y, Mayer L, Unkeless JC, Xiong H.

Cancer Res. 2019 Aug 15;79(16):4305. doi: 10.1158/0008-5472.CAN-19-1889. No abstract available.

PMID:
31416849
3.

Notch-1 signaling regulates intestinal epithelial barrier function, through interaction with CD4+ T cells, in mice and humans.

Dahan S, Rabinowitz KM, Martin AP, Berin MC, Unkeless JC, Mayer L.

Gastroenterology. 2011 Feb;140(2):550-9. doi: 10.1053/j.gastro.2010.10.057. Epub 2010 Nov 4.

4.

CCR7 deficiency in NOD mice leads to thyroiditis and primary hypothyroidism.

Martin AP, Marinkovic T, Canasto-Chibuque C, Latif R, Unkeless JC, Davies TF, Takahama Y, Furtado GC, Lira SA.

J Immunol. 2009 Sep 1;183(5):3073-80. doi: 10.4049/jimmunol.0900275. Epub 2009 Aug 12.

5.

AP-1 activated by toll-like receptors regulates expression of IL-23 p19.

Liu W, Ouyang X, Yang J, Liu J, Li Q, Gu Y, Fukata M, Lin T, He JC, Abreu M, Unkeless JC, Mayer L, Xiong H.

J Biol Chem. 2009 Sep 4;284(36):24006-16. doi: 10.1074/jbc.M109.025528. Epub 2009 Jul 10.

6.

Expression of the chemokine binding protein M3 promotes marked changes in the accumulation of specific leukocytes subsets within the intestine.

Shang L, Thirunarayanan N, Viejo-Borbolla A, Martin AP, Bogunovic M, Marchesi F, Unkeless JC, Ho Y, Furtado GC, Alcami A, Merad M, Mayer L, Lira SA.

Gastroenterology. 2009 Sep;137(3):1006-18, 1018.e1-3. doi: 10.1053/j.gastro.2009.05.055. Epub 2009 Jun 6.

7.

SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment.

Huang B, Lei Z, Zhang GM, Li D, Song C, Li B, Liu Y, Yuan Y, Unkeless J, Xiong H, Feng ZH.

Blood. 2008 Aug 15;112(4):1269-79. doi: 10.1182/blood-2008-03-147033. Epub 2008 Jun 4.

8.

Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria.

Shang L, Fukata M, Thirunarayanan N, Martin AP, Arnaboldi P, Maussang D, Berin C, Unkeless JC, Mayer L, Abreu MT, Lira SA.

Gastroenterology. 2008 Aug;135(2):529-38. doi: 10.1053/j.gastro.2008.04.020. Epub 2008 Apr 22.

9.

Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells.

Gu Y, Yang J, Ouyang X, Liu W, Li H, Yang J, Bromberg J, Chen SH, Mayer L, Unkeless JC, Xiong H.

Eur J Immunol. 2008 Jul;38(7):1807-13. doi: 10.1002/eji.200838331.

10.

Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t.

Yang J, Yang M, Htut TM, Ouyang X, Hanidu A, Li X, Sellati R, Jiang H, Zhang S, Li H, Zhao J, Ting AT, Mayer L, Unkeless JC, Labadia ME, Hodge M, Li J, Xiong H.

Eur J Immunol. 2008 May;38(5):1204-14. doi: 10.1002/eji.200838145.

11.

TLR signaling by tumor and immune cells: a double-edged sword.

Huang B, Zhao J, Unkeless JC, Feng ZH, Xiong H.

Oncogene. 2008 Jan 7;27(2):218-24. doi: 10.1038/sj.onc.1210904. Review.

PMID:
18176603
12.

Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling.

Huang B, Zhao J, Shen S, Li H, He KL, Shen GX, Mayer L, Unkeless J, Li D, Yuan Y, Zhang GM, Xiong H, Feng ZH.

Cancer Res. 2007 May 1;67(9):4346-52. Erratum in: Cancer Res. 2019 Aug 15;79(16):4306.

13.

IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways.

Zhao J, Kong HJ, Li H, Huang B, Yang M, Zhu C, Bogunovic M, Zheng F, Mayer L, Ozato K, Unkeless J, Xiong H.

J Biol Chem. 2006 Apr 14;281(15):10073-80. Epub 2006 Feb 16.

14.

Toll-like receptors on tumor cells facilitate evasion of immune surveillance.

Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC, Xiong H.

Cancer Res. 2005 Jun 15;65(12):5009-14. Erratum in: Cancer Res. 2005 Oct 1;65(19):9108. Chen, Shu-Hsia [added]. Cancer Res. 2019 Aug 15;79(16):4305.

15.

Ubiquitin-dependent degradation of interferon regulatory factor-8 mediated by Cbl down-regulates interleukin-12 expression.

Xiong H, Li H, Kong HJ, Chen Y, Zhao J, Xiong S, Huang B, Gu H, Mayer L, Ozato K, Unkeless JC.

J Biol Chem. 2005 Jun 24;280(25):23531-9. Epub 2005 Apr 18.

16.

Interaction of TRAF6 with MAST205 regulates NF-kappaB activation and MAST205 stability.

Xiong H, Li H, Chen Y, Zhao J, Unkeless JC.

J Biol Chem. 2004 Oct 15;279(42):43675-83. Epub 2004 Aug 11.

17.

Microtubule-associated serine/threonine kinase-205 kDa and Fc gamma receptor control IL-12 p40 synthesis and NF-kappa B activation.

Zhou H, Xiong H, Li H, Plevy SE, Walden PD, Sassaroli M, Prestwich GD, Unkeless JC.

J Immunol. 2004 Feb 15;172(4):2559-68.

18.

Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression.

Xiong H, Zhu C, Li H, Chen F, Mayer L, Ozato K, Unkeless JC, Plevy SE.

J Biol Chem. 2003 Jan 24;278(4):2271-7. Epub 2002 Nov 11.

19.

Convergence of Fc gamma receptor IIA and Fc gamma receptor IIIB signaling pathways in human neutrophils.

Chuang FY, Sassaroli M, Unkeless JC.

J Immunol. 2000 Jan 1;164(1):350-60.

20.

Inhibitory receptors, ITIM sequences and phosphatases.

Unkeless JC, Jin J.

Curr Opin Immunol. 1997 Jun;9(3):338-43. Review.

PMID:
9203414
21.

Soluble FcR block suppressor T cell activity at low concentration in vitro allowing isotype-specific antibody production.

Simpson SD, Snider DP, Zettel LA, Kiyono H, Unkeless JC, Ernst PB.

Cell Immunol. 1996 Jan 10;167(1):122-8.

PMID:
8548835
22.

Serum cytokine and anti-Fc gamma R autoantibody measurements in patients with systemic sclerosis.

Szegedi A, Czirják L, Unkeless JC, Boros P.

Acta Derm Venereol. 1996 Jan;76(1):21-3.

23.

Lateral mobility of Fc gamma RIIa is reduced by protein kinase C activation.

Zhang F, Yang B, Odin JA, Shen Z, Lin CT, Unkeless JC, Jacobson K.

FEBS Lett. 1995 Nov 27;376(1-2):77-80.

24.

Stoichiometry and thermodynamics of the interaction between the Fc fragment of human IgG1 and its low-affinity receptor Fc gamma RIII.

Ghirlando R, Keown MB, Mackay GA, Lewis MS, Unkeless JC, Gould HJ.

Biochemistry. 1995 Oct 17;34(41):13320-7.

PMID:
7577916
25.

Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma.

Davis K, Boros P, Keltz M, Unkeless JC, Fleischmajer R.

J Am Acad Dermatol. 1995 Oct;33(4):612-6.

PMID:
7673494
26.

The Ca2+ dependence of human Fc gamma receptor-initiated phagocytosis.

Edberg JC, Lin CT, Lau D, Unkeless JC, Kimberly RP.

J Biol Chem. 1995 Sep 22;270(38):22301-7.

27.

Function of human Fc gamma RIIA and Fc gamma RIIIB.

Unkeless JC, Shen Z, Lin CW, DeBeus E.

Semin Immunol. 1995 Feb;7(1):37-44. Review.

PMID:
7612894
28.
29.

Specificity and class distribution of Fc gamma R-specific autoantibodies in patients with autoimmune disease.

Boros P, Odin JA, Chen J, Unkeless JC.

J Immunol. 1994 Jan 1;152(1):302-6.

PMID:
8254199
30.

Fc receptor-mediated signal transduction.

Lin CT, Shen Z, Boros P, Unkeless JC.

J Clin Immunol. 1994 Jan;14(1):1-13. Review.

PMID:
8132732
31.

Lateral mobility of lipid analogues and GPI-anchored proteins in supported bilayers determined by fluorescent bead tracking.

Fein M, Unkeless J, Chuang FY, Sassaroli M, da Costa R, Väänänen H, Eisinger J.

J Membr Biol. 1993 Jul;135(1):83-92.

PMID:
8411132
32.

Autoantibodies directed against different classes of Fc gamma R are found in sera of autoimmune patients.

Boros P, Muryoi T, Spiera H, Bona C, Unkeless JC.

J Immunol. 1993 Mar 1;150(5):2018-24.

PMID:
8436832
33.

An Fc gamma RIII (CD16)-specific autoantibody from a patient with progressive systemic sclerosis.

Szegedi A, Boros P, Chen J, Kaffina M, Bona C, Unkeless JC.

Immunol Lett. 1993 Jan;35(1):69-76.

PMID:
8384599
34.

Regulation of phagocytosis and [Ca2+]i flux by distinct regions of an Fc receptor.

Odin JA, Edberg JC, Painter CJ, Kimberly RP, Unkeless JC.

Science. 1991 Dec 20;254(5039):1785-8.

PMID:
1837175
35.

IgM anti-Fc gamma R autoantibodies trigger neutrophil degranulation.

Boros P, Odin JA, Muryoi T, Masur SK, Bona C, Unkeless JC.

J Exp Med. 1991 Jun 1;173(6):1473-82.

36.

Molecular and functional studies of recombinant soluble Fc gamma receptors.

Sautès C, Varin N, Hogarth PM, Unkeless JC, Teillaud C, Even J, Lynch A, Fridman WH.

Mol Immunol. 1990 Dec;27(12):1201-7. Review. No abstract available.

PMID:
2148805
37.

Expression of murine Fc receptors for IgG.

Schreiber RE, Buku A, Unkeless JC.

J Immunol. 1990 Jun 15;144(12):4735-41.

PMID:
1693640
38.

Autoimmune mice make anti-Fc gamma receptor antibodies.

Boros P, Chen JM, Bona C, Unkeless JC.

J Exp Med. 1990 May 1;171(5):1581-95.

39.

Change in expression of Fc gamma RIII (CD16) on neutrophils from human immunodeficiency virus-infected individuals.

Boros P, Gardos E, Bekesi GJ, Unkeless JC.

Clin Immunol Immunopathol. 1990 Feb;54(2):281-9.

PMID:
2136822
40.

A specific Fc gamma receptor on cultured rat mesangial cells.

Santiago A, Satriano J, DeCandido S, Holthofer H, Schreiber R, Unkeless J, Schlondorff D.

J Immunol. 1989 Oct 15;143(8):2575-82.

PMID:
2529313
41.

Human Fc gamma receptors.

Unkeless JC.

Curr Opin Immunol. 1989 Oct;2(1):63-7. Review. No abstract available.

PMID:
2532914
42.

In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.

Kimberly RP, Edberg JC, Merriam LT, Clarkson SB, Unkeless JC, Taylor RP.

J Clin Invest. 1989 Sep;84(3):962-70.

43.

A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms.

Scallon BJ, Scigliano E, Freedman VH, Miedel MC, Pan YC, Unkeless JC, Kochan JP.

Proc Natl Acad Sci U S A. 1989 Jul;86(13):5079-83.

44.

Sideways killing: the cytolysis of Fc receptor-bearing cells through bridging to cytolytic T lymphocytes by antibodies specific for the T-cell receptor-T3 complex.

Ito M, Usuba O, Unkeless JC, Schreiber R, Celada F, Bona CA, Moran TM.

Scand J Immunol. 1989 Jun;29(6):659-69.

PMID:
2525807
45.

Function and heterogeneity of human Fc receptors for immunoglobulin G.

Unkeless JC.

J Clin Invest. 1989 Feb;83(2):355-61. Review. No abstract available.

46.

Human Fc receptors for IgG.

Unkeless JC.

Int Rev Immunol. 1989;5(2):165-71. Review.

PMID:
8691049
47.

Expression and characterization of a truncated murine Fc gamma receptor.

Qu ZX, Odin J, Glass JD, Unkeless JC.

J Exp Med. 1988 Mar 1;167(3):1195-210.

48.

Structure and function of human and murine receptors for IgG.

Unkeless JC, Scigliano E, Freedman VH.

Annu Rev Immunol. 1988;6:251-81. Review. No abstract available.

PMID:
2968084
49.

Properties of a second epitope of the murine Fc receptor for aggregated IgG.

Puré E, Witmer MD, Lum JB, Mellman I, Unkeless JC.

J Immunol. 1987 Dec 15;139(12):4152-8.

PMID:
2447161
50.

Soluble circulating Fc gamma receptors in human serum. A new ELISA assay for specific and quantitative detection.

Khayat D, Geffrier C, Yoon S, Scigliano E, Soubrane C, Weil M, Unkeless JC, Jacquillat C.

J Immunol Methods. 1987 Jun 26;100(1-2):235-41.

PMID:
2955053

Supplemental Content

Loading ...
Support Center